FF301 致：香港交易及結算所有限公司 公司名稱: Emperor Capital Group Limited 英皇資本集團有限公司（於百慕達註冊成立之有限公司） 呈交日期: 2026年1月5日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00717 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | 500,000,000,000 | HKD | | 0.01 | HKD | | 5,000,000,000 | | 增加 / 減少 (-) | | | 0 | | | HKD | | 0 | | 本月底結存 | | | 500,000,000,000 HKD | | 0.01 | HKD | | 5,000,000,000 | 本月底法定/註冊股本總額： HKD 5,000,000, ...

英皇資本集團有限公司董事會（「董事會」）成員載列如下 : 執行董事 楊玳詩女士 （主席） 朱允明先生 范敏嫦女士 獨立非執行董事 （於百慕達註冊成立之有限公司） （股份代號: 717） 董事名單與其角色和職能 董事會 黃德明先生 余擎天先生 陳嬋玲女士 附註: C 主席 M 成員 香港，2026年1月1日 董事委員會 董事會設立五個委員會。下表提供董事會成員在這些委員會中所擔任的職位。 | | 董事 委員會 | 審核委員會 | 薪酬委員會 | 提名委員會 | 企業管治 | 執行委員會 | | --- | --- | --- | --- | --- | --- | --- | | 董事 | | | | | 委員會 | | | 楊玳詩女士 | | | | M | | C | | 朱允明先生 | | | | | | M | | 范敏嫦女士 | | | M | | C | M | | 黃德明先生 | | M | C | M | | | | 余擎天先生 | | C | M | | M | | | 陳嬋玲女士 | | M | | C | M | | ...

Core Viewpoint - Emperor Capital (00717) reported a significant increase in total revenue and net profit for the fiscal year ending September 30, 2025, despite a decline in share price following the earnings announcement [1] Financial Performance - Total revenue reached approximately HKD 730 million, representing a year-on-year growth of 37.3% [1] - Net profit was approximately HKD 147 million, showing a substantial year-on-year increase of 121.4% [1] - Basic earnings per share were reported at 2.18 HKD cents [1] Dividend Policy - The company did not declare a final dividend for the period [1] Revenue Breakdown - The revenue from the loan segment was approximately HKD 180 million, which declined by 25% and accounted for 24.7% of total revenue [1] - The net impairment provision for margin loans, other loans, and advances significantly decreased to approximately HKD 43.2 million [1] Risk Management - The company emphasized its commitment to prudent policies, rigorous credit risk management, and monitoring mechanisms to reduce default risks [1] - Adjustments to interest rates and loan valuation ratios were made in response to market conditions [1]

Core Viewpoint - Emperor Capital (00717) reported a significant increase in total revenue and net profit for the fiscal year ending September 30, 2025, but the stock price fell over 5% following the earnings announcement [1] Financial Performance - Total revenue reached approximately HKD 730 million, representing a year-on-year growth of 37.3% [1] - Net profit was approximately HKD 147 million, showing a substantial increase of 121.4% compared to the previous year [1] - Basic earnings per share were reported at 2.18 HKD cents [1] Revenue Breakdown - The revenue from the loan segment was approximately HKD 180 million, which declined by 25%, accounting for 24.7% of total revenue [1] - The net impairment provision for margin loans, other loans, and advances significantly decreased to approximately HKD 43.2 million [1] Dividend Policy - The company did not declare a final dividend for the reporting period [1]

Company News - Emperor Capital (00717.HK) reported total revenue of approximately HKD 730 million for the year ending September 30, 2025, representing a year-on-year increase of 37.3%. Net profit reached approximately HKD 147 million, up 121.4% year-on-year [2] - New Special Energy (01799.HK) plans to sell a 79.92% stake in Xinjiang Wind Power New Energy Partnership for approximately HKD 1.337 billion to facilitate a REITs issuance [2] - Bay Area Development (00737.HK) signed a construction contract for the Shenzhen section with a contract value of RMB 1.448 billion [2] - Weichai Power (03393.HK) won a bid for the Brazil CPFL project with a contract amount exceeding HKD 80 million [3] - WuXi AppTec (02359.HK) invested approximately EUR 30 million to acquire a 3.22% stake in a French biopharmaceutical fund [3] - Joy Spreader Group (02473.HK) established a long-term strategic cooperation with New Stone Technology in areas such as autonomous vehicle procurement and market promotion [3] - Fosun Pharma (02196.HK) signed a cooperation and option agreement with Clavis Bio to jointly advance preclinical development of selected target compounds [3] - CSPC Pharmaceutical Group (01093.HK) reported top-line analysis data from the Phase III clinical trial of its drug, Truxima [3] - Yihai International (01662.HK) announced a strategic cooperation between Trio AI and HGC [4] Financing and Buyback Activities - Zhi Yuan Holdings (00990.HK) plans to issue a total of 515 million new shares at a discount of approximately 1.4%, aiming to raise about HKD 355.3 million [5] - Tencent Holdings (00700.HK) repurchased 1.055 million shares for HKD 636 million, with buyback prices ranging from HKD 599.5 to HKD 605.5 [5] - Xiaomi Group-W (01810.HK) repurchased 3.75 million shares for HKD 151 million, with buyback prices between HKD 40.12 and HKD 40.24 [6] - COSCO Shipping Holdings (01919.HK) repurchased 5.9 million shares for HKD 80.6 million, with buyback prices from HKD 13.52 to HKD 13.76 [7] - Kuaishou-W (01024.HK) repurchased 1.235 million shares for HKD 80.2 million, with buyback prices ranging from HKD 64.35 to HKD 65.60 [7] - Geely Automobile (00175.HK) repurchased 1.908 million shares for HKD 31.8 million, with buyback prices between HKD 16.26 and HKD 16.8 [8]

Core Viewpoint - Emperor Capital (00717) reported a significant increase in financial performance for the fiscal year ending September 30, 2025, with total revenue reaching approximately HKD 730 million, representing a year-on-year growth of 37.3% [1] - The net profit surged to around HKD 147 million, marking a remarkable year-on-year increase of 121.4% [1] - Basic earnings per share were reported at HKD 0.0218 [1] Financial Performance - Total revenue for the year was approximately HKD 730 million, reflecting a growth of 37.3% compared to the previous year [1] - Net profit reached about HKD 147 million, which is an increase of 121.4% year-on-year [1] - Basic earnings per share stood at HKD 0.0218 [1]

Core Viewpoint - The company, Emperor Capital (00717.HK), reported a significant increase in total revenue and net profit for the fiscal year 2024/2025, driven by its focus on developing global financial market business segments [1] Financial Performance - Total revenue increased by 37.3% to HKD 730 million [1] - Net impairment losses on margin loans, other loans, and advances decreased significantly to HKD 43.2 million, down from HKD 158.9 million in 2024 [1] - Net profit rose to HKD 146.9 million, compared to HKD 66.4 million in 2024 [1] - Basic earnings per share were HKD 0.0218, up from HKD 0.0098 in 2024, while diluted earnings per share were HKD 0.0217 [1] Market Environment - The macroeconomic environment remains challenging and complex, influenced by geopolitical tensions, debt issues, global tariff policies, inflation pressures, and high unemployment rates [1] - These adverse factors continue to impact global financial markets, leading both businesses and individuals to seek alternative investment opportunities in the stock market and wealth investment solutions [1]

Group 1 - The core viewpoint of the article highlights the significant financial performance of Emperor Capital (00717) for the fiscal year ending September 30, 2025, with total revenue reaching approximately HKD 730 million, representing a year-on-year growth of 37.3% [1] - The net profit for the company was approximately HKD 147 million, showing a substantial year-on-year increase of 121.4% [1] - The basic earnings per share were reported at HKD 0.0218 [1]

Financial Performance - Total revenue for the fiscal year ending September 30, 2025, increased by 37.3% to HKD 729.9 million, compared to HKD 531.6 million in 2024[5] - Revenue from the global financial markets segment surged by 94.5% to HKD 540.7 million, accounting for 74.1% of total revenue[10] - Net profit rose significantly by 121.4% to HKD 146.9 million, up from HKD 66.4 million in the previous year[6] - Total revenue for the year ended September 30, 2025, was HKD 729,872,000, an increase from HKD 531,628,000 in 2024, representing a growth of approximately 37.2%[22] - The group reported a pre-tax profit of HKD 146,926,000 for the year, compared to HKD 66,130,000 in 2024, reflecting a significant increase[22] - Basic earnings per share for the year were HKD 0.0218, up from HKD 0.0098 in 2024[22] - The company reported a pre-tax profit of HKD 146,936,000 for 2025, compared to HKD 66,361,000 in 2024, marking a 109.5% increase[45] - Basic earnings per share increased to HKD 2.18, up from HKD 0.98 in 2024, reflecting a growth of 122.4%[45] Revenue Breakdown - Commission and fee income contributed HKD 495,788,000, while interest income accounted for HKD 234,084,000, indicating strong performance in financial markets and lending segments[32] - The segment performance for financial markets showed a profit of HKD 66,554,000, while the lending segment reported HKD 110,309,000, leading to a total segment profit of HKD 178,513,000[33] - Commission and fee income from securities trading rose to HKD 84,425,000, up 53.1% from HKD 55,138,000 in 2024[39] - Interest income from margin financing and IPOs increased to HKD 55,291,000, up 27.0% from HKD 43,549,000 in 2024[39] Asset and Liability Management - As of September 30, 2025, the group's current assets and current liabilities were HKD 5,703,300,000 and HKD 2,304,300,000, respectively, compared to HKD 4,977,100,000 and HKD 1,813,500,000 in 2024[14] - The group reported a total cash and bank balance of HKD 2,353,800,000 as of September 30, 2025, up from HKD 1,520,800,000 in 2024[14] - Total assets increased to HKD 5,703,284 thousand in 2025, up from HKD 4,977,052 thousand in 2024, representing a growth of approximately 14.6%[23] - Current liabilities rose to HKD 2,304,295 thousand in 2025, compared to HKD 1,813,521 thousand in 2024, marking an increase of about 27.1%[23] - Net current assets improved to HKD 3,398,989 thousand in 2025, up from HKD 3,163,531 thousand in 2024, reflecting a growth of approximately 7.4%[23] - Non-current assets decreased to HKD 221,345 thousand in 2025 from HKD 296,774 thousand in 2024, a decline of about 25.4%[23] - The company’s total liabilities increased to HKD 3,482,128 thousand in 2025, up from HKD 2,267,746 thousand in 2024, reflecting a rise of approximately 53.4%[23] Impairment and Provisions - The impairment provision decreased by 72.8% to HKD 43.2 million, compared to HKD 158.9 million in 2024[5] - The impairment provision for the year was HKD 43,200,000, significantly lower than HKD 158,900,000 in 2024[16] - The group recognized a net impairment provision of approximately HKD 113,400,000 for loans and advances due to credit impairment stages[18] - Impairment provisions for loans and advances decreased to HKD 913,633,000 in 2025 from HKD 840,261,000 in 2024, indicating improved asset quality[48] Corporate Actions and Future Outlook - The company completed the acquisition of Crosby Asia Limited, enhancing its institutional financial services and research capabilities[10] - The outlook for the company remains positive, with expectations of increased IPO applications driven by Chinese tech companies attracting global investors[13] - The company plans to strengthen its global financial markets team to drive growth in brokerage, wealth management, and asset management services[13] - The successful implementation of the new Capital Investment Entrant Scheme (CIES) is expected to provide significant opportunities for tailored investment services[9] Dividend and Shareholder Information - The board has decided not to recommend any final dividend for the year, consistent with 2024[21] - The company did not declare any dividends for 2025, consistent with 2024[44] - The company’s issued and paid-up share capital remains at HKD 67,408,000 as of September 30, 2025, unchanged from the previous year[57] Compliance and Governance - The independent auditor confirmed that the financial statements for the year ended September 30, 2025, are in accordance with applicable accounting standards[60] - The company has adopted its own code of conduct for securities trading, which meets or exceeds the standards set out in the Listing Rules Appendix C3[62] - The annual performance announcement has been published on the Hong Kong Stock Exchange website and the company's website[64]

Group 1 - The core point of the article is the appointment of Mr. Zhu Yunming as an executive director and member of the executive committee of Emperor Capital, effective from January 1, 2026 [1]